BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 875371)

  • 1. Morphology of mammary gland, ovaries and pituitary gland of hydroxylamine-fed C3H/HeN mice.
    Evarts RP; Brown CA
    Lab Invest; 1977 Jul; 37(1):53-63. PubMed ID: 875371
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of anterior pituitary isograft in the neonatal female mouse in the pattern of estrous cycle and the structure of mammary glands.
    Mori T
    Endocrinol Jpn; 1974 Jun; 21(3):205-9. PubMed ID: 4473336
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition by ergocornine and 2-Br-alpha-ergocryptin of spontaneous mammary tumor appearance in mice.
    Yanai R; Nagasawa H
    Experientia; 1971 Aug; 27(8):934-5. PubMed ID: 5147266
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of hydroxylamine on the morphology of the rat mammary gland and on the induction of mammary tumors by 7,12-dimethylbenz[a]anthracene.
    Evarts RP; Brown CA; Atta GJ
    Exp Mol Pathol; 1979 Jun; 30(3):337-48. PubMed ID: 109309
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxylamine effects on cryptogenic neoplasm development in C3H mice.
    Stenbäck F; Weisburger JH; Williams GM
    Cancer Lett; 1987 Dec; 38(1-2):73-85. PubMed ID: 3690516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action of medroxyprogesterone (Provera) on the pituitary gland, mammary glands and ovaries of the female rat].
    Ectors F; Pasteels JL; Herlant M
    C R Acad Hebd Seances Acad Sci D; 1966 Dec; 263(25):1988-91. PubMed ID: 4963932
    [No Abstract]   [Full Text] [Related]  

  • 7. 6-Methyl-8-beta-ergoline-acetonitrile (MEA)-induced suppression of mammary tumorigenesis in C3H/HeJ female mice.
    Welsch CW; Gribler C; Clemens JA
    Eur J Cancer (1965); 1974 Sep; 10(9):595-600. PubMed ID: 4477735
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of pituitary-induced nodular hyperplasia in mammary glands of C3H mice fed a phenylalanine-deficient diet.
    Hui YH; DeOme KB; Briggs GM
    J Natl Cancer Inst; 1971 May; 46(5):929-39. PubMed ID: 4333726
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of ergot drugs on prolactin and growth hormone secretion, and on mammary nucleic acid content in C3H-Bi mice.
    Sinha YN; Selby FW; VanderLaan WP
    J Natl Cancer Inst; 1974 Jan; 52(1):189-91. PubMed ID: 4810962
    [No Abstract]   [Full Text] [Related]  

  • 10. Caloric restriction perturbs the pituitary-ovarian axis and inhibits mouse mammary tumor virus production in a high-spontaneous-mammary-tumor-incidence mouse strain (C3H/SHN).
    Koizumi A; Masuda H; Wada Y; Tsukada M; Kawamura K; Kamiyama S; Walford RL
    Mech Ageing Dev; 1989 Aug; 49(2):93-104. PubMed ID: 2552231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649
    [No Abstract]   [Full Text] [Related]  

  • 12. Response of C3H (mect) -- a subline of C3H strain-to gonadectomy.
    Pai SR
    Indian J Cancer; 1976 Mar; 13(1-3E760611-761022-3):70-5. PubMed ID: 965028
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the action mechanism of estrogens and progesterone on mammary glands].
    Suetina IA; Chentsov IuS; Smirnova IO; Samoĭlov VI
    Arkh Patol; 1966; 28(10):16-22. PubMed ID: 6012321
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of sulpiride on the rat genital tract, mammary gland and anterior pituitary gland].
    Lanza M; Picard D; Carlon N
    C R Seances Soc Biol Fil; 1971; 165(6):1363-8. PubMed ID: 4262045
    [No Abstract]   [Full Text] [Related]  

  • 15. Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol.
    Bennett LM; McAllister KA; Malphurs J; Ward T; Collins NK; Seely JC; Gowen LC; Koller BH; Davis BJ; Wiseman RW
    Cancer Res; 2000 Jul; 60(13):3461-9. PubMed ID: 10910057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen effects on mammary gland morphology and ovarian activity in Macaca fascicularis.
    Lee AE; Dukelow WR
    J Med Primatol; 1981; 10(2-3):102-9. PubMed ID: 7200148
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolactin and growth hormone levels in the anterior pituitary of rats bearing mammary tumor induced by 7,12-dimethylbenz [a] anthracene.
    Yanai R; Nagasawa H
    Gan; 1968 Dec; 59(6):543-6. PubMed ID: 5721587
    [No Abstract]   [Full Text] [Related]  

  • 18. Some discrepancies between the use of DNA synthesis and wholemount preparations as indices of mammary gland response to pituitary mammotrophin.
    Nagasawa H; Yanai R
    J Endocrinol; 1975 Nov; 67(2):303-4. PubMed ID: 1206283
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoplastic responses and correlated plasma prolactin levels in diethylstilbestrol-treated ACI and Sprague-Dawley rats.
    Stone JP; Holtzman S; Shellabarger CJ
    Cancer Res; 1979 Mar; 39(3):773-8. PubMed ID: 427764
    [No Abstract]   [Full Text] [Related]  

  • 20. Requirement of essential fatty acids in the diet for development of the mouse mammary gland.
    Knazek RA; Liu SC; Bodwin JS; Vonderhaar BK
    J Natl Cancer Inst; 1980 Feb; 64(2):377-82. PubMed ID: 6928228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.